NiMin finds buyer for California oil assets
Latest newsNiMin Energy is selling its San Joaquin Valley assets for $27 million, inching closer to the dissolution of the company. The news comes after NiMin, an independent oil and gas firm based in Carpinteria, said earlier this week that it is selling its Wyoming assets for $98 million and dissolving the company. For the past Read More →
Deckers stock slips as profits drop 59%
Banking & Finance, Earnings, Latest news, Tri-County Public CompaniesUnseasonably warm weather dampened first-quarter profits at Ugg boot maker Deckers Outdoor Corp and sent its share price tumbling more than 18 percent after the earnings announcement. The Goleta-based footwear company reported April 26 that quarterly profits were down 59 percent to $7.9 million, or 20 cents per share. The earnings drop came even as Read More →
FCAL profits drop 83%
Banking & Finance, Earnings, Latest news, Tri-County Public CompaniesFirst California Financial Group’s first-quarter profits plummeted 83.3 percent to $2.6 million, it reported on April 26. Per share, earnings were 8 cents, compared to 54 cents in the same quarter a year earlier. The Westlake Village-based parent of First California Bank said last year’s first-quarter results included a one-time $34.7 million pre-tax gain related Read More →
Ryland trims first-quarter loss as home sales pop
Banking & Finance, Earnings, Latest news, Tri-County Public CompaniesNational homebuilder Ryland Group narrowed its first-quarter loss to $3 million from $17.4 milllion as orders for new homes jumped 46.6 percent. Ryland’s revenue climbed 28.7 percent year-over-year to $215.9 million as home orders and closings rose in tandem with average closing prices. The company, which last year moved its headquarters to Westlake Village, said Read More →
Amgen to buy Turkish firm in $700M deal
Latest news, Technology, Tri-County Public CompaniesThousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
